ExLibris header image
SFX Logo
Title: Nature of coenzyme binding by glyceraldehyde-3-phosphate dehydrogenase: carbon-13 NMR studies with oxidized [4-13C]nicotinamide adenine dinucleotide
Source:

Journal of the American Chemical Society [0002-7863] Klepp, Juergen yr:1989


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. HUANG, FY. "THE CONFORMATIONS OF TRIMETHOPRIM ESCHERICHIA-COLI DIHYDROFOLATE-REDUCTASE COMPLEXES - A N-15 AND P-31 NMR-STUDY." FEBS letters 283.1 (1991): 44-46. Link to SFX for this item
2. MORAN, RG. "A RAPID AND CONVENIENT PREPARATION OF [NADP-4-H-3 AND STEREOSPECIFICALLY TRITIATED NADPH-3." Analytical biochemistry 138.1 (1984): 196-204. Link to Full Text for this item Link to SFX for this item
3. Kritsky, M. "Investigation of the photochemical properties of biopterin and its reduced forms." Applied biochemistry and microbiology 45.1 (2009): 104-109. Link to SFX for this item
4. VALERA, V. "SYNTHESIS OF 4R-TRITIUM AND 4S-TRITIUM LABELED NADPH FOR THE DETERMINATION OF THE COENZYME STEREOSPECIFICITY OF NADPH-PROTOCHLOROPHYLLIDE OXIDOREDUCTASE." Biochemical and biophysical research communications 148.1 (1987): 515-520. Link to Full Text for this item Link to SFX for this item
5. CAYLEY, PJ. "P-31 NMR-STUDIES OF COMPLEXES OF NADPH AND NADP+ WITH ESCHERICHIA-COLI DIHYDROFOLATE-REDUCTASE." International journal of biological macromolecules 2.4 (1980): 251-255. Link to Full Text for this item Link to SFX for this item
6. Matei, V. "Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats." Journal of Hepatology 49.2 (2008): 192-197. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.